The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of salmonella-IL2 in combination with FOLFIRINOX on overall and progression-free survival in stage IV metastatic pancreatic cancer.
 
Daniel Saltzman
Employment - Salspera
Leadership - Salspera
Stock and Other Ownership Interests - Salspera
Patents, Royalties, Other Intellectual Property - I hold several patents for Salmonella-IL2 which I have assigned to Salspera.
Expert Testimony - numerous hospital systems
 
Petr Kavan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical
 
Lance Augustin
Stock and Other Ownership Interests - ANVS, ADXL,ESPR, CRMD - publicly traded stock ownership
Patents, Royalties, Other Intellectual Property - attenuated bacteria patents
 
Janet Schottel
Patents, Royalties, Other Intellectual Property - Patents - Attenuated Bacteria
 
James Lee
No Relationships to Disclose
 
Jordan Moradian
Employment - Salspera (I); SSIPHOX
Leadership - Salspera (I)
Stock and Other Ownership Interests - Salspera (I)
Consulting or Advisory Role - Salspera
Patents, Royalties, Other Intellectual Property - Salspera (I)
(OPTIONAL) Uncompensated Relationships - Salspera
 
Eddie Moradian
Employment - Salspera - CEO
Leadership - MD Bioproducts; Salspera
Stock and Other Ownership Interests - MD Bioproducts; Salspera
Patents, Royalties, Other Intellectual Property - Salspera
 
Gerald Batist
No Relationships to Disclose